Literature DB >> 1379130

The spectrum of action of new immunosuppressive drugs.

A W Thomson.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1379130      PMCID： PMC1554449          DOI： 10.1111/j.1365-2249.1992.tb06927.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

1.  A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.

Authors:  Y Kokado; M Ishibashi; H Jiang; S Takahara; T Sonoda
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

2.  First International Congress on FK 506. August 21-24, 1991, Pittsburgh, PA.

Authors: 
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.

Authors:  S C Wang; A Zeevi; M L Jordan; R L Simmons; D J Tweardy
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Authors:  F J Dumont; M J Staruch; S L Koprak; M R Melino; N H Sigal
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

5.  The effects of CP 17193, an immunosuppressive pyrazaloquinoline, on the development of spontaneous lupus disease in NZBW F1 hybrid mice.

Authors:  R V Bundick; R P Eady
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

6.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.

Authors:  W M Flanagan; B Corthésy; R J Bram; G R Crabtree
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

7.  FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.

Authors:  A de Paulis; R Cirillo; A Ciccarelli; M Condorelli; G Marone
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

8.  Facilitation of specific tolerance induction in adult mice by RS-61443.

Authors:  L Hao; F Calcinaro; R G Gill; E M Eugui; A C Allison; K J Lafferty
Journal:  Transplantation       Date:  1992-03       Impact factor: 4.939

9.  RS-61443--a phase I clinical trial and pilot rescue study.

Authors:  H W Sollinger; M H Deierhoi; F O Belzer; A G Diethelm; R S Kauffman
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

10.  Human islet isolation and allotransplantation in 22 consecutive cases.

Authors:  C Ricordi; A G Tzakis; P B Carroll; Y J Zeng; H L Rilo; R Alejandro; A Shapiro; J J Fung; A J Demetris; D H Mintz
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939
View more
  5 in total

1.  Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

Authors:  F Nicoletti; P Zaccone; R Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

2.  Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.

Authors:  F Nicoletti; R Di Marco; S Morrone; P Zaccone; D Lembo; S Grasso; A Santoni; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

3.  Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity.

Authors:  A S Bansal; W Ollier; M N Marsh; R S Pumphrey; P B Wilson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

4.  Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin.

Authors:  F Nicoletti; M O Borghi; P L Meroni; W Barcellini; C Fain; R Di Marco; R Menta; H U Schorlemmer; G Bruno; G Magro
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

5.  Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.

Authors:  A W Thomson; J Woo; G Z Yao; S Todo; T E Starzl; A Zeevi
Journal:  Transpl Immunol       Date:  1993       Impact factor: 1.708
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.